These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18633613)
1. Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia. Manna A; Cadenotti L; Motto A; Ballo P Ann Hematol; 2009 Jan; 88(1):91-2. PubMed ID: 18633613 [No Abstract] [Full Text] [Related]
2. Complications of therapy in cancer patients: Case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia. Gettinger S; Shapira I; Scheinfeld N; Grossbard M J Clin Oncol; 2004 Nov; 22(22):4648-9. PubMed ID: 15542816 [No Abstract] [Full Text] [Related]
3. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia. Gallipoli P; Drummond MW Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859 [No Abstract] [Full Text] [Related]
4. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia. Parma M; Casaroli I; Pogliani EM Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387 [No Abstract] [Full Text] [Related]
5. All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide. Ganguly S Leuk Res; 2005 Jun; 29(6):721. PubMed ID: 15863216 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia. Takitani K; Koh M; Inoue A; Kawakami C; Kuno T; Tamai H Am J Hematol; 2006 Sep; 81(9):720-1. PubMed ID: 16838336 [No Abstract] [Full Text] [Related]
10. All-trans-retinoic acid-induced scrotal ulcerations in a patient with acute promyelocytic leukemia. Esser AC; Nossa R; Shoji T; Sapadin AN J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):316-7. PubMed ID: 10906659 [TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia. Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519 [TBL] [Abstract][Full Text] [Related]
13. Fournier's gangrene and scrotal ulcerations during all-trans-retinoic acid therapy for acute promyelocytic leukemia. Naithani R; Kumar R; Mahapatra M Pediatr Blood Cancer; 2008 Aug; 51(2):303-4. PubMed ID: 18421710 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary embolism in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Jiménez-Yuste V; Martín MP; Canales M; Ojeda E; Hernández-Navarro F Leukemia; 1997 Nov; 11(11):1988-9. PubMed ID: 9369438 [No Abstract] [Full Text] [Related]
15. [High fever during the treatment of acute promyelocytic leukemia with all-trans retinoic acid]. Shirono K; Igarashi N; Tsuda H Rinsho Ketsueki; 1997 Jul; 38(7):622-4. PubMed ID: 9267168 [TBL] [Abstract][Full Text] [Related]
16. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia. Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177 [No Abstract] [Full Text] [Related]
17. Scrotal ulcerations during all-transretinoic acid therapy for acute promyelocytic leukemia. Ramzi J; Hend BN; Lamia A; Raihane BL; Hela BA; Zaher BA; Balkis M Ann Hematol; 2007 Apr; 86(4):289-90. PubMed ID: 17205289 [No Abstract] [Full Text] [Related]
18. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. Raza S; Ullah K; Ahmed P; Khan B J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891 [TBL] [Abstract][Full Text] [Related]
19. Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia. Mourad YA; Jabr F; Salem Z Int J Dermatol; 2005 Jan; 44(1):68-9. PubMed ID: 15663666 [TBL] [Abstract][Full Text] [Related]
20. The race and dose of chemotherapy should be considered for optimizing maintenance therapy for acute promyelocytic leukemia. Nagai S; Nannya Y; Hangaishi A; Takahashi T; Kurokawa M Leuk Res; 2009 Oct; 33(10):1427-9. PubMed ID: 19375796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]